Dany Gargot
Blois, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 05, 2024
The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: November 17, 2022
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patients.
Journal: Scandinavian journal of gastroenterology
Published: June 20, 2022
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristics.
Journal: Scandinavian journal of gastroenterology
Published: February 21, 2022
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 23, 2020
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: February 12, 2019
Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 23, 2016
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 27, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 28, 2015
Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 06, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026